carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma [published online April 4, 2018]. Leuk Lymphoma. 2018:1-7. doi: 10.1080/10428194.2018.1443337.
Advertisement
Articles by carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma [published online April 4, 2018]. Leuk Lymphoma. 2018:1-7. doi: 10.1080/10428194.2018.1443337.
Advertisement
Latest Updated Articles
- Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple Myeloma
Published: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
2
Communication of Launch Prices by Drug Companies, 2022-2024
3
Top 5 Most-Read News Stories of 2025
4
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
5
